Consider an illustrative presentation: a 5-year-old with fever, lethargy, oliguria, a blood pressure of 58/32 mmHg, mottled skin, five-second capillary refill, and weak pulses is in decompensated shock, with infection high on the list. Her exam fits the traditional “cold” phenotype. The trap is treating that label as a direct measurement of cardiac output—and concluding that epinephrine is mandatory. The useful question is what the exam makes plausible, what it cannot establish, and how that distinction should shape vasoactive choice.
Cold shock is a bedside pattern, not a hemodynamic measurement
Classically, cold shock is associated with low cardiac output and high systemic vascular resistance; warm shock is associated with high output and low resistance. These are useful teaching patterns, not diagnoses that can be confirmed by skin temperature or pulse quality alone.
Cool extremities, delayed refill, and weak pulses indicate poor peripheral perfusion and fit the cold pattern. They do not measure cardiac output, establish elevated vascular resistance, or prove that the left ventricle is failing. Sepsis can produce mixed physiology, and myocardial dysfunction may coexist with vasodilation or intravascular volume depletion.
| Finding | What it supports | What it does not establish |
|---|---|---|
| Cool extremities, weak pulses, prolonged refill | Poor peripheral perfusion; a traditional cold-shock pattern | Low cardiac output, high vascular resistance, or primary pump failure |
| Gallop, hepatomegaly, new crackles, worsening respiratory status | Concern for cardiac dysfunction or poor fluid tolerance | The cause of the dysfunction by itself |
| Cardiac and lung point-of-care ultrasound, when performed by a trained clinician | Information about ventricular function and pulmonary congestion | A complete hemodynamic diagnosis or a reason to delay resuscitation |
The differential still matters. Consider distributive septic shock, sepsis-associated myocardial dysfunction, and volume depletion from poor intake or losses; more than one may be present. Myocarditis or another cardiac cause deserves attention if the history, examination, ECG, or ultrasound points that way. The vignette provides no prior medical or cardiac history or echocardiogram, so do not infer ventricular dysfunction.
Why epinephrine is reasonable—and why it is not automatic
Epinephrine acts at both alpha and beta adrenergic receptors. Its beta effects can increase heart rate and myocardial contractility, while alpha effects contribute to vascular tone. That mixed action gives epinephrine a sound physiologic rationale when low-output physiology or myocardial dysfunction is suspected.
Norepinephrine has strong alpha-mediated vasoconstrictor effects and also beta activity. It is not a pure vasoconstrictor, and it is not reserved exclusively for a “warm” exam. Either drug may be a reasonable initial choice; the patient’s evolving physiology, local protocol, and the team’s ability to monitor and titrate the infusion matter.
A useful exam answer is conditional: epinephrine offers inotropic support and is reasonable when low-output physiology is suspected, but cold extremities alone do not prove that physiology or make epinephrine the only acceptable agent. If a stem explicitly documents cardiac dysfunction, that strengthens the rationale for valuing inotropy. This case does not supply that finding.
Let current guidance correct the shortcut
The 2025 AHA/AAP Pediatric Advanced Life Support guidance considers either epinephrine or norepinephrine reasonable as an initial vasoactive infusion for fluid-refractory septic shock. The 2026 Surviving Sepsis Campaign guideline likewise does not identify a preferred first-line agent, citing insufficient evidence to choose between them. The guidelines do not say the drugs are interchangeable in every child; they caution against presenting one as a universal winner.
Timing is also not a fixed arithmetic rule. For systems with intensive care available, the 2026 guideline suggests crystalloid boluses in 10–20 mL/kg aliquots, up to 40–60 mL/kg during the first hour, with reassessment after each bolus and discontinuation if shock resolves or fluid overload appears. It found insufficient evidence to recommend starting vasoactive medication before versus after 40 mL/kg. A fluid total should not become a prerequisite when poor perfusion persists or further fluid is unsafe.
In this child, obtain cultures when doing so will not substantially delay treatment, start empiric antimicrobials as soon as possible, and continue perfusion support in parallel. If shock persists, involve pediatric critical care and start a vasoactive infusion according to the local pathway. Current guidance favors using suitable peripheral venous access rather than delaying therapy solely to place a central line; monitor the access site and the child closely.
Reassess the child, not just the label
Track blood pressure, pulse quality, capillary refill, mental status, urine output, respiratory findings, and the response to each intervention. New hepatomegaly, crackles, or worsening oxygenation should prompt a fresh look at fluid tolerance. Point-of-care ultrasound can add useful information when expertise is available, but it is an adjunct—not a reason to pause treatment in a child with profound hypotension.
A rising heart rate after epinephrine is not, by itself, evidence that the drug is wrong or that shock is worsening. Conversely, a higher blood pressure alone does not prove that tissue perfusion has recovered. Interpret trends together, and adjust the plan when the overall response does not fit the expected physiology.
Common traps worth correcting
- “Cold shock means epinephrine, full stop.” The exam supports a possible low-output pattern; it does not establish cardiac output or ventricular function.
- “Norepinephrine is only for warm shock.” That turns a helpful teaching contrast into a rigid rule and overlooks norepinephrine’s beta activity.
- “Finish 40 mL/kg before starting a pressor.” Current guidance does not set that universal sequence; reassess perfusion and fluid tolerance.
- “The heart rate rose, so the vasoactive choice failed.” Judge the whole perfusion picture, not one vital sign in isolation.
Practical takeaways
- Cold extremities, weak pulses, and delayed refill identify poor perfusion; they do not directly measure cardiac output or systemic vascular resistance.
- Epinephrine’s combined beta and alpha actions make it a reasonable choice when inotropic support is desired, not an automatic choice based on skin temperature alone.
- Current pediatric guidance supports either epinephrine or norepinephrine as an initial vasoactive option for fluid-refractory septic shock; it does not establish one as universally preferred.
- Reassess after each fluid bolus, do not wait for a fixed volume or central line when vasoactive support is needed, and follow the child’s response over time.
